ReNeuron Group Plc Product Insights, Trends & Market Analysis 2015 - PowerPoint PPT Presentation

Loading...

PPT – ReNeuron Group Plc Product Insights, Trends & Market Analysis 2015 PowerPoint presentation | free to download - id: 7ecb11-OWRhM



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

ReNeuron Group Plc Product Insights, Trends & Market Analysis 2015

Description:

This report provides comprehensive information on the current therapeutic developmental pipeline of ReNeuron Group Plc s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Enquiry @ – PowerPoint PPT presentation

Number of Views:19

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: ReNeuron Group Plc Product Insights, Trends & Market Analysis 2015


1
ReNeuron Group Plc Product Pipeline Review - 2015
Published on October - 2015
2
.
Report Overview
About ReNeuron Group Plc Product Pipeline Review
2015 Global Markets Directs, ReNeuron Group Plc
Product Pipeline Review - 2015, provides an
overview of the ReNeuron Group Plc s
pharmaceutical research and development focus.
This report provides comprehensive information on
the current therapeutic developmental pipeline of
ReNeuron Group Plcs, complete with comparative
analysis at various stages, therapeutics
assessment by drug target, mechanism of action
(MoA), route of administration (RoA) and molecule
type. It also reviews latest updates, and
featured news and press releases, along with
special features on late-stage and discontinued
projects. Global Markets Directs report features
investigational drugs from across globe covering
over 20 therapy areas and nearly 3,000
indications. The report is built using data and
information sourced from Global Markets Directs
proprietary data bases, Company/University
websites, SEC filings, investor presentations and
featured press releases from company/university
sites and industry-specific third party sources,
put together by Global Markets Directs team. Get
Full Details On http//www.researchbeam.com/rene
uron-group-plc-product-pipeline-review-2015-market

3
.
Report Overview
Drug profiles/records featured in the report
undergoes periodic updation following a stringent
set of processes that ensures that all the
profiles are updated with the latest set of
information. Additionally, processes including
live news deals tracking, browser based
alert-box and clinical trials registries tracking
ensure that the most recent developments are
captured on a real time basis. The report
enhances decision making capabilities and help to
create effective counter strategies to gain
competitive advantage. It strengthens RD
pipelines by identifying new targets and MOAs to
produce first-in-class and best-in-class
products. Note Certain sections in the report
may be removed or altered based on the
availability and relevance of data for the
indicated disease. Scope The report provides
brief overview of ReNeuron Group Plc including
business description, key information and facts,
and its locations and subsidiaries The report
reviews current pipeline of ReNeuron Group Plc s
human therapeutic division and enlists all their
major and minor projects
4
.
Report Overview
The report features product description and
descriptive mechanism of action for key pipeline
products along with the products developmental
history and major milestones Special feature on
out-licensed and partnered product portfolio The
report summarizes all the dormant and
discontinued pipeline projects Latest company
statement Latest news and deals relating to the
ReNeuron Group Plc s pipeline products   Reasons
to buy Evaluate ReNeuron Group Plc s strategic
position with total access to detailed
information on its product pipeline Assess the
growth potential of ReNeuron Group Plc in its
therapy areas of focus Identify new drug targets
and therapeutic classes in the ReNeuron Group Plc
s RD portfolio and develop key strategic
initiatives to reinforce pipeline in those
areas Exploit in-licensing opportunities by
identifying windows of opportunity to fill
portfolio gaps
5
Report Overview
  • Develop strategic initiatives by understanding
    the focus areas of ReNeuron Group Plc and exploit
    collaboration and partnership opportunities
  • Identify emerging players with potentially strong
    product portfolio and create effective
    counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by
    identifying the most promising pipeline of
    ReNeuron Group Plc
  • Develop and design in-licensing and out-licensing
    strategies by identifying prospective partners
    with the most attractive projects to enhance and
    expand business potential and Scope
  • Explore the dormant and discontinued projects of
    ReNeuron Group Plc and identify potential
    opportunities in those areas
  • Avoid Intellectual Property Rights related issues

6
Table Of Contents
List of Tables 4 List of Figures 4 ReNeuron Group
Plc Snapshot 5 ReNeuron Group Plc Overview 5 Key
Information 5 Key Facts 5 ReNeuron Group Plc -
Research and Development Overview 6 Key
Therapeutic Areas 6 ReNeuron Group Plc - Pipeline
Review 8 Pipeline Products by Stage of
Development 8 Pipeline Products - Monotherapy
9 Pipeline Products - Partnered Products
10 Partnered Products/Combination Treatment
Modalities 11 ReNeuron Group Plc - Pipeline
Products Glance 12
7
Table Of Contents
ReNeuron Group Plc - Clinical Stage Pipeline
Products 12 Phase II Products/Combination
Treatment Modalities 12 Phase I
Products/Combination Treatment Modalities
13 ReNeuron Group Plc - Early Stage Pipeline
Products 14 IND/CTA Filed Products/Combination
Treatment Modalities 14 ReNeuron Group Plc - Drug
Profiles 15 ReN-001 15 Product Description
15 Mechanism of Action 15 RD Progress 15 ReN-009
17 Product Description 17 Mechanism of Action
17 RD Progress 17
8
Table Of Contents
ReN-003 18 Product Description 18 Mechanism of
Action 18 RD Progress 18 ReNeuron Group Plc -
Pipeline Analysis 20 ReNeuron Group Plc -
Pipeline Products by Route of Administration
20 ReNeuron Group Plc - Pipeline Products by
Molecule Type 21 ReNeuron Group Plc - Recent
Pipeline Updates 22 ReNeuron Group Plc - Dormant
Projects 29 ReNeuron Group Plc - Company
Statement 30 ReNeuron Group Plc - Locations And
Subsidiaries 31 Enquiry about this report _at_
http//www.researchbeam.com/reneuron-group-plc-pro
duct-pipeline-review-2015-market/enquire-about-rep
ort
9
FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/reneuron-group-plc-pro
duct-pipeline-review-2015-market
Stay With Us
5933 NE Win Sivers Drive, 205, Portland, OR
97220 United States
TELEPHONE 1 (800) 910-6452 E-MAIL
sales_at_researchbeam.com
About PowerShow.com